Insider trade

Officer received an award of 1,876 AMGN shares

Traded Mar 3, 2026 · Filed Mar 6, 2026

AmgenAMGN

1,876
Shares

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 3, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 6, 2026

OfficerGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references dividend reinvestment

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000318154-26-000019
Filed / recorded

Mar 6, 2026, 1:39 AM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

AMGEN INC

Issuer CIK

318154

Ticker

AMGN

Reporting person

Rachna Khosla

Relationship

Officer

Officer title

SVP, Business Development

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Mar 3, 2026

Transaction code

A

Shares / units

1,876

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

8,972

Ownership form

Direct

Amendment

No

Footnotes from the filing

These shares include 107 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.